AYTU - Aytu BioScience, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Aytu BioScience, Inc.

373 Inverness Parkway
Suite 206
Englewood, CO 80112
United States

Full Time Employees61

Key Executives

NameTitlePayExercisedYear Born
Mr. Joshua R. DisbrowChairman & CEO465kN/A1975
Mr. David A. GreenCFO, Sec. & Treasurer345kN/A1963
Mr. Jarrett T. Disbrow Ph.D.Exec. VP of Corp. Devel.355kN/A1975
Mr. Matthew V. PhillipsExec. VP of Commercial OperationsN/AN/A1968
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Aytu BioScience, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension. It also offers ZolpiMist, an oral spray for the treatment of insomnia; and MiOXSYS, an in vitro diagnostic semen analysis test that is used in the measurement of static oxidation reduction potential in human semen. Aytu BioScience, Inc. is based in Englewood, Colorado.

Corporate Governance

Aytu BioScience, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.